biomarkers

Precision Medicine: Using Genetics to Drive Treatment Decisions

02/15/2016

JCP Editors

The emphasis on precision medicine continues as health care providers discover the value of using information about a patient’s particular disease to inform treatment approaches. Genetic testing and personalized...

The...

02/15/2016

Journal of Clinical Pathways

Research in Review

Predictive Biomarker for Panitumumab Therapy Effectiveness in Patients With Colorectal Cancer

02/12/2016

JCP Editors

Expression of epidermal growth factor receptor ligands epiregulin (EREG) and amphiregulin (AREG) may help determine which patients with colorectal cancer are the most likely to benefit from panitumumab therapy. The...

...

02/12/2016

Journal of Clinical Pathways

Research in Review

New Assay More Sensitive for Identifying CML Remission Likely to Relapse

02/10/2016

JCP Editors

A new personalized DNA-based digital polymerase chain reaction (dPCR) assay could help determine which patients with chronic myeloid leukemia (CML) are more likely to relapse while in molecular remission. Advances...

A new...

02/10/2016

Journal of Clinical Pathways

Research in Review

Prognostic Value of Colon Cancer Biomarkers Depends on DNA Mismatch Repair Status

01/25/2016

JCP Editors

Mutations of the BRAF and KRAS genes may be associated with worse outcomes in certain patients with colon cancer, according to a new study. The use of BRAF and KRAS as prognostic indicators in colon cancer has been...

...

01/25/2016

Journal of Clinical Pathways

Research in Review

Effectiveness of Drug for First-Line Treatment of EGFR+ Non-Small Cell Lung Cancer Supported by New Study

01/08/2016

JCP Editors

First-line treatment with erlotinib for epidermal growth factor receptor (EGFR) mutation–positive non-small cell lung cancer (NSCLC) patients may have benefits even after disease progresses, a new study...

...

01/08/2016

Journal of Clinical Pathways

Research in Review

Immunotherapy Drug Improves Overall Survival in Patients With NSCLC

12/30/2015

JCP Editors

Favorable results for pembrolizumab, a PD-1/PD-L1 inhibitor only recently approved for the treatment of non-small-cell lung cancer (NSCLC), were found in a trial comparing the drug’s effectiveness to that of the...

...

12/30/2015

Journal of Clinical Pathways

Research in Review

New MRI Technique Non-invasively Detects Biomarker for Lung Cancer

12/11/2015

JCP Editors

Researchers from Georgia State University, Atlanta, have developed a new imaging technique to better track cancer progression of the lung and prostate, according to a study published in Scientific Reports. The team,...

...

12/11/2015

Journal of Clinical Pathways

Research in Review

New Gene Identified as Key Indicator of Lung Cancer Prognosis

11/11/2015

JCP Editors

A breakthrough in the research of one of the deadliest forms of cancer may bring new understanding and better treatment to the disease. Worldwide, lung cancer is the leading cause of death among all cancer types....

A...

11/11/2015

Journal of Clinical Pathways